Home » Topics » Disease categories and therapies » Infection

Infection
RSS

IDSA highlights: IntraBiotics presents results of successful ramoplanin phase II trial

Nov. 25, 1999

Topical antifungal agents with in vitro and in vivo efficacy developed at Hanwha

Nov. 24, 1999

Microcide's novel cephalosporin antibiotic enters the clinic

Nov. 24, 1999

Solid-phase synthesis and use of novel inhibitors of aspartyl proteases reported by Pharmacopeia

Nov. 23, 1999

New data presented on Pentose's product for viral inactivation of blood components

Nov. 22, 1999

SSP and Nippon Kayaku codevelop antifungal triazole

Nov. 19, 1999

News from AASP: preclinical PK data for PNU-179954 support further development

Nov. 19, 1999

New anti-HCMV compound from BioChem Pharma shows favorable PK profile in mice

Nov. 19, 1999

Neuraminidase inhibitors a focus of investigation at Abbott

Nov. 19, 1999

New antibacterial agents from Bayer exert good activity against staphylococci

Nov. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...